|
|
|
Insider
Information: |
Patel Snehal |
Relationship: |
CEO and CFO, Director,... |
City: |
Stafford |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
5,350,777 |
|
Indirect Shares
|
2,712,886 |
|
|
Direct
Value |
$76,944,173 |
|
|
Indirect Value
|
$39,011,301 |
|
|
Total
Shares |
8,063,663 |
|
|
Total
Value |
$115,955,474 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Greenwich Lifesciences, Inc. |
GLSI |
CEO and CFO, Director,... |
2024-04-01 |
5,350,777 |
2022-06-24 |
2,712,886 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GLSI |
Greenwich Lifesciences, I... |
CHIEF EXECUTIVE OFFICEROfficer |
|
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
749,336 |
|
- |
|
GLSI |
Greenwich Lifesciences, I... |
CHIEF EXECUTIVE OFFICEROfficer |
|
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,232,284 |
|
- |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2020-09-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
304,489 |
1,168,172 |
0 |
- |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2020-09-29 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,360,635 |
129,400 |
0 |
- |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2020-09-29 |
4 |
B |
$4.60 |
$76,710 |
D/D |
16,667 |
1,184,839 |
2.81 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2020-11-19 |
4 |
B |
$5.40 |
$10,795 |
D/D |
2,000 |
1,186,839 |
2.81 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2020-09-29 |
4 |
B |
$5.75 |
$657,495 |
D/D |
114,347 |
863,683 |
2.81 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-06-16 |
4 |
B |
$7.13 |
$57,040 |
D/D |
8,000 |
2,683,886 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-06-02 |
4 |
B |
$7.38 |
$49,992 |
D/D |
6,774 |
1,223,703 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-06-14 |
4 |
B |
$7.91 |
$94,920 |
D/D |
12,000 |
2,675,886 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2023-10-25 |
4 |
B |
$7.91 |
$19,775 |
D/D |
2,500 |
5,301,677 |
3.15 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2023-10-26 |
4 |
B |
$7.97 |
$19,925 |
D/D |
2,500 |
5,304,177 |
3.15 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-06-10 |
4 |
B |
$8.33 |
$99,960 |
D/D |
12,000 |
2,663,886 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-06-03 |
4 |
B |
$8.35 |
$77,238 |
D/D |
9,250 |
1,232,953 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-06-07 |
4 |
B |
$8.55 |
$51,300 |
D/D |
6,000 |
1,238,953 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2023-10-04 |
4 |
B |
$8.63 |
$17,260 |
D/D |
2,000 |
5,298,177 |
3.15 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-11-02 |
4 |
B |
$8.79 |
$17,580 |
D/D |
2,000 |
2,721,886 |
3.15 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2023-09-19 |
4 |
B |
$8.95 |
$35,800 |
D/D |
4,000 |
5,296,177 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2023-10-10 |
4 |
B |
$9.07 |
$9,070 |
D/D |
1,000 |
5,299,177 |
3.15 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2023-11-03 |
4 |
B |
$9.11 |
$31,885 |
D/D |
3,500 |
5,307,677 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-06-24 |
4 |
B |
$9.13 |
$59,025 |
I/I |
6,465 |
2,712,886 |
2.64 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-06-24 |
4 |
B |
$9.13 |
$205,745 |
D/D |
22,535 |
2,706,421 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2023-07-21 |
4 |
B |
$9.20 |
$9,200 |
D/D |
1,000 |
5,288,177 |
3.15 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-09-29 |
4 |
B |
$9.23 |
$9,230 |
D/D |
1,000 |
2,713,886 |
3.15 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2022-09-30 |
4 |
B |
$9.46 |
$9,460 |
D/D |
1,000 |
2,714,886 |
3.15 |
% |
|
62 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|